Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease
- PMID: 7710374
- DOI: 10.1001/archneur.1995.00540280065020
Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease
Abstract
Objective: To investigate whether changes in the cerebral cortex exhibit similar distribution patterns in both disorders of Down's syndrome and Alzheimer's disease, we performed a comparative neuropathologic study of patients with these disorders to further clarify the possible relationships between these dementing conditions.
Design: The regional and laminar distribution and density of neurofibrillary tangles and senile plaques were analyzed in the cerebral cortex of a series of 16 patients (aged 6 to 74 years) with Down's syndrome and in 10 elderly individuals with Alzheimer's disease.
Results: Quantitative analyses revealed that the time course of neurofibrillary tangle formation in Down's syndrome displays regional patterns comparable with those observed in aging and Alzheimer's disease with layer II of the entorhinal cortex being affected first in Down's syndrome, followed by the hippocampus proper and neocortex. The oldest patients with Down's syndrome had neurofibrillary tangle densities sometimes higher than in patients with Alzheimer's disease. At variance with Alzheimer's disease, amyloid deposition was widespread in all of the cortical areas investigated and was observed much earlier than neurofibrillary tangle formation. Patients with Down's syndrome also frequently had higher senile plaque densities than patients with Alzheimer's disease.
Conclusions: These results indicate that the development of pathologic changes in patients with Down's syndrome does not parallel that observed in elderly individuals and patients with Alzheimer's disease in all respects. However, the comparable development patterns of neurofibrillary tangle formation suggest that detailed analysis of patients with Down's syndrome may be useful to further our knowledge of the mechanisms underlying the installation of the neuropathologic alterations leading to the demonstrated loss of select neuronal populations in Alzheimer's disease.
Similar articles
-
Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.Arch Neurol. 1995 Apr;52(4):373-8. doi: 10.1001/archneur.1995.00540280059019. Arch Neurol. 1995. PMID: 7710373
-
Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts.Brain Res Brain Res Rev. 1997 Oct;25(2):217-45. doi: 10.1016/s0165-0173(97)00023-4. Brain Res Brain Res Rev. 1997. PMID: 9403139 Review.
-
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.Brain. 2004 Apr;127(Pt 4):811-24. doi: 10.1093/brain/awh101. Epub 2004 Feb 25. Brain. 2004. PMID: 14985261
-
Quantitative analysis of neuropathologic changes in the cerebral cortex of centenarians.Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jul;19(4):577-92. doi: 10.1016/0278-5846(95)00103-3. Prog Neuropsychopharmacol Biol Psychiatry. 1995. PMID: 8588057
-
Alzheimer's disease in Down's syndrome. A review.J Am Geriatr Soc. 1986 Oct;34(10):728-34. doi: 10.1111/j.1532-5415.1986.tb04304.x. J Am Geriatr Soc. 1986. PMID: 2944942 Review.
Cited by
-
Cryo-EM structures of amyloid-β and tau filaments in Down syndrome.Nat Struct Mol Biol. 2024 Jun;31(6):903-909. doi: 10.1038/s41594-024-01252-3. Epub 2024 Mar 29. Nat Struct Mol Biol. 2024. PMID: 38553642 Free PMC article.
-
Symptoms and age of prodromal Alzheimer's disease in Down syndrome: a systematic review and meta-analysis.Neurol Sci. 2024 Jun;45(6):2445-2460. doi: 10.1007/s10072-023-07292-9. Epub 2024 Jan 16. Neurol Sci. 2024. PMID: 38228941 Review.
-
Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer's Disease Associated with Down Syndrome.Int J Mol Sci. 2023 Jul 18;24(14):11596. doi: 10.3390/ijms241411596. Int J Mol Sci. 2023. PMID: 37511361 Free PMC article.
-
Plasma NT1-tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts.Alzheimers Dement. 2023 Dec;19(12):5755-5764. doi: 10.1002/alz.13382. Epub 2023 Jul 12. Alzheimers Dement. 2023. PMID: 37438872
-
Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.Free Neuropathol. 2022 Jul 8;3:3-17. doi: 10.17879/freeneuropathology-2022-3806. eCollection 2022 Jan. Free Neuropathol. 2022. PMID: 37284149 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical